Compile Data Set for Download or QSAR
Report error Found 113 Enz. Inhib. hit(s) with all data for entry = 12700
TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720810(US20250051375, Compound 20)
Affinity DataEC50:  0.700nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720792(US20250051375, Compound 2)
Affinity DataEC50:  2.10nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720875(US20250051375, Compound 85)
Affinity DataEC50:  2.40nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720868(US20250051375, Compound 78)
Affinity DataEC50:  3.10nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720859(US20250051375, Compound 69)
Affinity DataEC50:  3.5nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720811(US20250051375, Compound 21)
Affinity DataEC50:  3.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720877(US20250051375, Compound 87)
Affinity DataEC50:  3.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720874(US20250051375, Compound 84)
Affinity DataEC50:  3.90nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720861(US20250051375, Compound 71)
Affinity DataEC50:  3.90nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720876(US20250051375, Compound 86)
Affinity DataEC50:  4.10nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720863(US20250051375, Compound 73)
Affinity DataEC50:  4.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720862(US20250051375, Compound 72)
Affinity DataEC50:  5.40nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720858(US20250051375, Compound 68)
Affinity DataEC50:  5.90nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720860(US20250051375, Compound 70)
Affinity DataEC50:  6.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720791(US20250051375, Compound 1)
Affinity DataEC50:  7.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720865(US20250051375, Compound 75)
Affinity DataEC50:  8.10nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720867(US20250051375, Compound 77)
Affinity DataEC50:  8.30nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720812(US20250051375, Compound 22)
Affinity DataEC50:  9.90nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720854(US20250051375, Compound 64)
Affinity DataEC50:  11.1nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720855(US20250051375, Compound 65)
Affinity DataEC50:  12.6nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720894(US20250051375, Compound 104)
Affinity DataEC50:  17.6nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720794(US20250051375, Compound 4)
Affinity DataEC50:  20.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720796(US20250051375, Compound 6)
Affinity DataEC50:  20.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720797(US20250051375, Compound 7)
Affinity DataEC50:  23.2nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720802(US20250051375, Compound 12)
Affinity DataEC50:  23.4nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720882(US20250051375, Compound 92)
Affinity DataEC50:  37.1nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720809(US20250051375, Compound 19)
Affinity DataEC50:  38.9nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720830(US20250051375, Compound 40)
Affinity DataEC50:  40.5nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720827(US20250051375, Compound 37)
Affinity DataEC50:  41.8nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720890(US20250051375, Compound 100)
Affinity DataEC50:  42.4nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720878(US20250051375, Compound 88)
Affinity DataEC50:  42.8nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720831(US20250051375, Compound 41)
Affinity DataEC50:  43.5nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720832(US20250051375, Compound 42)
Affinity DataEC50:  49.1nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720892(US20250051375, Compound 102)
Affinity DataEC50:  54.1nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720883(US20250051375, Compound 93)
Affinity DataEC50:  55.8nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720884(US20250051375, Compound 94)
Affinity DataEC50:  59nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720881(US20250051375, Compound 91)
Affinity DataEC50:  60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720891(US20250051375, Compound 101)
Affinity DataEC50:  60.6nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720806(US20250051375, Compound 16)
Affinity DataEC50:  62.2nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720815(US20250051375, Compound 25)
Affinity DataEC50:  62.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720829(US20250051375, Compound 39)
Affinity DataEC50:  64.4nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720888(US20250051375, Compound 98)
Affinity DataEC50:  64.6nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720825(US20250051375, Compound 35)
Affinity DataEC50:  65.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720823(US20250051375, Compound 33)
Affinity DataEC50:  65.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720842(US20250051375, Compound 52)
Affinity DataEC50:  67.2nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720795(US20250051375, Compound 5)
Affinity DataEC50:  73.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720833(US20250051375, Compound 43)
Affinity DataEC50:  85.9nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720899(US20250051375, Compound 109)
Affinity DataEC50:  90.5nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720844(US20250051375, Compound 54)
Affinity DataEC50:  94nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720793(US20250051375, Compound 3)
Affinity DataEC50:  96.6nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

Displayed 1 to 50 (of 113 total ) | Next | Last >>
Jump to: